Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsApollohospitalsenterprises

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy Emami, Sintex, Apollo Hospitals, DLF

      Dharmesh Kant of India Nivesh Securities recommends buying PTC India Financial Services with a target of Rs 49.

    • Apollo Hospitals may test Rs 1460: Rahul Mohindar

      According to Rahul Mohindar of Viratechindia.com, Apollo Hospitals may test Rs 1460.

    • Apollo Hospitals may move to Rs 1480-1490: Amit Gupta

      Amit Gupta of ICICIdirect feels that Apollo Hospitals Enterprises may move to Rs 1480-1490.

    • Apollo Hospitals short selling idea: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Apollo Hospitals, Motherson Sumi and Eicher Motors are short selling ideas.

    • Bull's Eye: Sell BHEL, M&M Fin, buy HDIL, Voltas, UCO Bank

      Gaurav Ratnaparkhi of Sharekhan suggests buying LIC Housing Finance with a target of Rs 449.

    • Buy Apollo Hospitals Ent 1450 Call, advises VK Sharma

      VK Sharma of HDFC Securities recommends buying Apollo Hospitals Enterprises 1450 Call.

    • Apollo Hospital should outperform, target Rs 1600: Mohindar

      Rahul Mohindar of viratechindia.com is of the view that Apollo Hospitals Enterprises should outperform and may hit Rs 1600 in the long term.

    • Bull's Eye: Reliance Comm, Eicher Motors, sell Bharat Forge

      According to Shahina Mukadam, Market Expert, one may sell Jain Irrigation with a target of Rs 68 and buy Fed Llyod with a target of Rs 87.

    • Apollo Hospitals may hit Rs 1400, says Kunal Bothra

      Kunal Bothra of LKP Securities is of the view that Apollo Hospitals may test Rs 1400.

    • Buy Apollo Hospitals futures at Rs 1290: VK Sharma

      VK Sharma of HDFC Securities recommends buying Apollo Hospitals futures at Rs 1290.

    • Buy HDFC Bank, Apollo Hospitals, Reliance Ind: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying HDFC Bank, Apollo Hospitals Enterprises and Reliance Industries.

    • Book partial profit in Apollo Hospitals: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can book partial profits in Apollo Hospitals.

    • Buy Apollo Hospitals Enterprises: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Apollo Hospitals Enterprises.

    • Expect upside in Apollo Hospitals: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com expects Apollo Hospitals Enterprises to break on the upside.

    • Go long in Apollo Hospitals: Amit Harchekar

      Amit Harchekar of A Plus Analytics recommends going long in Apollo Hospitals with a target of Rs 1500.

    • Sell Apollo Hospitals; buy Lupin: Kunal Saraogi

      Kunal Saraogi of Equityrush recommends selling Apollo Hospitals and advises buying Lupin.

    • Buy JSW Energy, Apollo Hospitals: Kunal Bothra

      Kunal Bothra of LKP Securities recommends buying JSW Energy and Apollo Hospitals.

    • Go long in Dr Reddy's Labs: Amit Gupta

      Amit Gupta of ICICIdirect is of the view that one can go long in Dr Reddy's Laboratories and feels that Apollo Hospitals Enterprises may hit Rs 1540-1550.

    • Buy Apollo Hospitals Enterprises: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Apollo Hospitals Enterprises as the stock may test Rs 1800.

    • Expect 5-6% upside in Cipla, Dr Reddy's: Rahul Mohindar

      Rahul Mohindar of viratechindia.com is of the view that one may see 5-6 percent upside in Cipla and Dr Reddy's Labs.

    • Buy Apollo Hospitals, Aurobindo Pharma: Gaurav Bissa

      Gaurav Bissa of LKP Securities is of the view that one may buy Aditya Birla Nuvo with a target of Rs 1800.

    • Buy Zee Entertainment, target Rs 375-380: Hemant Thukral

      Hemant Thukral of Aditya Birla Money recommends buying Zee Entertainment with a target of Rs 375-380 and feels that Apollo Hospitals may test Rs 1390-1400.

    • Buy Apollo Hospitals, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may buy Apollo Hospitals as the stock may head higher.

    • Go long in Apollo Hospitals: Amit Gupta

      Amit Gupta of ICICIdirect recommends going long in Apollo Hospitals Enterprises and expects 7-8 percent upside in it.

    • Sell ONGC; buy BHEL, Apollo Hospitals: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling ONGC and advises buying BHEL and Apollo Hospitals.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347